-
Mashup Score: 5Tissue-sparing Surgery | Cancer Today - 2 year(s) ago
A clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.
Source: www.cancertodaymag.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
In response to the need for cancer screening and care in Appalachia, ACCC—together with several of its state chapters—launched the Appalachian Community Cancer Alliance in December 2021.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
November is Lung Cancer Awareness Month and ACCC’s Rural Appalachian Lung Cancer Screening Initiative is proud to join the cause in creating awareness and increasing lung cancer screening! Read more about the RALCS initiative: https://t.co/hYmh761QAK #LungCancerAwarenessMonth https://t.co/xiPPtdPW6L
-
-
Mashup Score: 0
Study suggests lung cancer surgery leads to longer survival than radiation, but radiation remains an important option.
Source: www.cancertodaymag.orgCategories: General Medicine News, Onc News and JournalsTweet-
November is #LungCancerAwarenessMonth. Standard treatments for early-stage lung cancers are surgical removal or radiation therapy, both of which deliver good results. However, @CancerTodayMag reports that surgery may be more effective. Learn more: https://t.co/d23jC9wvnF
-
-
Mashup Score: 3FDA approves repotrectinib - 2 year(s) ago
FDA approves repotrectinib for ROS1-positive non-small cell lung cancer
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
Yesterday, the @US_FDA approved repotrectinib, a tyrosine kinase inhibitor, for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Learn more: https://t.co/FdUxso7mwD November is #LungCancerAwarenessMonth.
-
-
Mashup Score: 1FDA approves repotrectinib - 2 year(s) ago
FDA approves repotrectinib for ROS1-positive non-small cell lung cancer
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet-
Yesterday, the @US_FDA approved repotrectinib, an ALK inhibitor, for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Learn more: https://t.co/w0bCtMBgCz November is #LungCancerAwarenessMonth.
-
-
Mashup Score: 0Lung Cancer Prevention | How to Prevent Lung Cancer - 2 year(s) ago
There is no sure way to prevent lung cancer, but the best way to reduce your risk is to avoid smoking and tobacco. Learn more about cancer prevention.
Source: www.cancer.orgCategories: General Medicine News, PayerTweet-
There are several ways you can reduce your risk for lung cancer including avoiding tobacco and radon exposure, as well as maintaining a healthy diet.* Remember to take care of your lungs so they can take care of you in return! #LungCancerAwarenessMonth *https://t.co/HsOHQjMRcQ https://t.co/JFPyTyE3kg
-
-
Mashup Score: 3
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
Gavitt A. Woodard, MD, is an award-winning surgeon researcher who is trying to better understand why, how, and when some semi-solid lung lesions transition to a more solid, aggressive form of lung cancer. https://t.co/ySOFmuUwPB @GavittWoodard @YaleMed #LungCancerAwarenessMonth https://t.co/v5XkbglGrc
-
-
Mashup Score: 14
Appropriate risk stratification of indeterminate pulmonary nodules (IPNs) is necessary to direct diagnostic evaluation. Currently available models wer…
Source: www.sciencedirect.comCategories: General Medicine News, PulmonologyTweet-
Godfrey and colleagues found the TREAT 2.0 model predicted the probability of lung cancer in a high cancer prevalence clinical setting with high accuracy and good calibration. Read more in the November issue of @journal_CHEST: https://t.co/IwCYSUSYwV #LungCancerAwarenessMonth https://t.co/TpKWegUhrN
-
-
Mashup Score: 7Lung Cancer News From 2023 - 2 year(s) ago
CURE® highlights some of the most significant lung cancer news of 2023 in honor of Lung Cancer Awareness Month.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Stay informed about the latest advancements in lung cancer research and treatment from 2023. #lungcancerawarenessmonth https://t.co/QDMnbxQqN9 https://t.co/RrCa6ItRFK
-
-
Mashup Score: 5
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
Gavitt A. Woodard, MD, is an award-winning surgeon researcher who is trying to better understand why, how, and when some semi-solid lung lesions transition to a more solid, aggressive form of lung cancer. https://t.co/ySOFmuUwPB @GavittWoodard @YaleMed #LungCancerAwarenessMonth https://t.co/v5XkbglGrc
-
November is #LungCancerAwarenessMonth. The standard treatment for certain stage I NSCLC patients is surgical removal of an entire lobe of the lung. @CancerTodayMag reports that a procedure that preserves more tissue may provide equal benefit. Learn more: https://t.co/LO6dJCkDFm